HealthcareServices

Global Molecular Tumor Board Solutions Market Trends and Growth Analysis 2025–2029

November 21, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Anticipated Size Of The Molecular Tumor Board Solutions Market Over The Five-Year Period 2025–2029?

The molecular tumor board solutions market has experienced swift expansion recently. Projections indicate its size will expand from $1.34 billion in 2024 to $1.53 billion in 2025, showing a compound annual growth rate (CAGR) of 13.9%. Historically, this expansion has been driven by factors such as the greater uptake of genomic profiling, a heightened need for precision oncology, increased understanding of molecular diagnostics, the broadening of cancer research efforts, and enhanced partnerships between hospitals and biotechnology companies.

The molecular tumor board solutions market size is anticipated to expand rapidly over the next few years, projecting an increase to $2.53 billion by 2029, achieving a compound annual growth rate (CAGR) of 13.5%. This growth during the forecast period is primarily driven by the increasing demand for multidisciplinary tumor boards, the expansion of cloud-based molecular data platforms, growing regulatory support for genomic testing, a heightened focus on patient-centric oncology care, and the rising incidence of cancer cases. Prominent trends for the same forecast period include ongoing developments in genomic sequencing tools, substantial investment in research and development for molecular solutions, innovation in clinical decision support software, advancements in data analytics and visualization, and the integration of machine learning for refining treatment recommendations.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28274&type=smp

What Are The Emerging Market Drivers Creating New Opportunities In The Molecular Tumor Board Solutions Industry?

The expanding occurrence of cancer is projected to fuel the advancement of the molecular tumor board solutions market moving ahead. Cancer, a collection of illnesses, is defined by the unrestrained multiplication and dissemination of atypical cells within the body. This growing incidence of cancer stems from lifestyle decisions like inadequate nutrition, tobacco use, sedentary habits, and excessive drinking of alcohol. Molecular tumor board solutions contribute to cancer management by offering an expert, diverse review of patients’ genetic and clinical information, thus facilitating tailored treatment approaches. These solutions improve clinical judgments through the incorporation of molecular profiling and insights generated by AI, which in turn enhances patient results and the accuracy of treatments. An illustrative example is that in October 2024, data from the National Health Service, a UK-based government department, showed new cancer diagnoses increased by 5% from 329,664 in 2021 to 346,217 in 2022, amounting to an average of 948 cases daily. Consequently, the escalating occurrence of cancer is a key factor propelling the expansion of the molecular tumor board solutions market.

Which Key Segments Fueling The Molecular Tumor Board Solutions Market?

The molecular tumor board solutions market covered in this report is segmented as

1) By Component: Software, Services

2) By Deployment Mode: On-Premises, Cloud-Based

3) By Application: Clinical Decision Support, Genomic Data Interpretation, Patient Management, Other Applications

4) By End-User: Hospitals, Cancer Centers, Research Institutes, Other End-Users

Subsegments:

1) By Software: Clinical Decision Support, Data Analytics, Reporting And Visualization, Integration Platforms

2) By Services: Consulting, Implementation, Training And Support, Maintenance And Upgrades

Which Market Trends Are Creating New Opportunities In The Molecular Tumor Board Solutions Industry?

Major companies operating in the molecular tumor board solutions market are focusing on developing innovative solutions, such as molecular profiling tests, to enhance the precision and effectiveness of cancer diagnostics and treatment planning. Molecular profiling tests are diagnostic tools that analyze a tumor’s genetic and molecular characteristics to inform personalized cancer treatment decisions. For instance, in April 2025, Guardant Health Inc., a US-based biotechnology and precision oncology company, launched Guardant360 Tissue, an innovative molecular profiling test for tumor tissue that integrates comprehensive multiomic analysis, including DNA, RNA, AI-powered PD-L1, and genome-wide methylation data. This advanced test, powered by the Guardant Infinity smart liquid biopsy platform, provides a more complete and multidimensional view of cancer, enabling higher resolution tumor classification and subtyping. Guardant360 Tissue delivers results in under two weeks, is covered by Medicare for eligible patients, and aims to enhance precision oncology by providing deeper insights to guide treatment decisions, including for therapies such as poly (ADP-ribose) polymerase (PARP) inhibitors and immunotherapies.

Which Key Market Players Are Investing In Expansion And Innovation Of Molecular Tumor Board Solutions Market?

Major companies operating in the molecular tumor board solutions market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Siemens Healthineers AG, Koninklijke Philips N.V., Illumina Inc., Novogene Co. Ltd., QIAGEN N.V., Myriad Genetics Inc., BGI Genomics Co. Ltd., Guardant Health Inc., Caris Life Sciences Inc., Mayo Clinic Laboratories, Sectra AB, GenomOncology LLC, MedGenome Labs Ltd., Burning Rock Biotech Limited, NantHealth Inc., SOPHiA GENETICS SA, Variantyx Inc., Baylor Genetics, Molecular Health GmbH, PierianDx Inc., Oncompass Medicine, and CureMatch Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/molecular-tumor-board-solutions-global-market-report

Which Region Is Projected To Lead The Molecular Tumor Board Solutions Market During The Forecast Period?

North America was the largest region in the molecular tumor board solutions market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in molecular tumor board solutions report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request A Customized Version Of The Molecular Tumor Board Solutions Market Report:

https://www.thebusinessresearchcompany.com/customise?id=28274&type=smp

Browse Through More Reports Similar to the Global Molecular Tumor Board Solutions Market 2025, By The Business Research Company

Circulating Tumor Cells Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/circulating-tumor-cells-global-market-report

Anti Cancer Mabs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/anti-cancer-mabs-global-market-report

Oncology Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/oncology-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795